Beryl Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Beryl Capital Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-288,887	Closed	-$1.17M	–	32
2023 Q4	$1.17M	Buy	+288,887	New	+$881K	0.64%	17

Beryl Capital Management's THRX Position: Q1 2024 in Review

Beryl Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 288,887 shares — an estimated $1.17M sold.

Beryl Capital Management first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $1.17M in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Beryl Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Beryl Capital Management sold 288,887 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1.17M.
Beryl Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Beryl Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $1.17M in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Beryl Capital Management's 13F filing for Q1 2024, filed 15 May 2024.